UK markets closed
NIKKEI 225
37,552.16 +113.55 (+0.30%) HANG SENG
16,828.93 +317.24 (+1.92%) CRUDE OIL
83.39 +0.03 (+0.04%) GOLD FUTURES
2,335.70 -6.40 (-0.27%) DOW
38,503.69 +263.71 (+0.69%) Bitcoin GBP
53,365.34 -210.10 (-0.39%)
BioLife Solutions, Inc. (BLFS)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 760.13M |
| Enterprise value | 751.13M |
| Trailing P/E | N/A |
| Forward P/E | 250.00 |
| PEG ratio (5-yr expected) | 63.20 |
| Price/sales (ttm) | 5.12 |
| Price/book (mrq) | 2.25 |
| Enterprise value/revenue | 5.24 |
| Enterprise value/EBITDA | -16.60 |
Trading information
Stock price history
| Beta (5Y monthly) | 1.69 |
| 52-week change 3 | -7.39% |
| S&P500 52-week change 3 | 23.06% |
| 52-week high 3 | 24.50 |
| 52-week low 3 | 8.92 |
| 50-day moving average 3 | 17.43 |
| 200-day moving average 3 | 15.35 |
Share statistics
| Avg vol (3-month) 3 | 372.39k |
| Avg vol (10-day) 3 | 368.77k |
| Shares outstanding 5 | 45.3M |
| Implied shares outstanding 6 | 47.43M |
| Float 8 | 32.62M |
| % held by insiders 1 | 3.54% |
| % held by institutions 1 | 102.45% |
| Shares short (28 Mar 2024) 4 | 3.2M |
| Short ratio (28 Mar 2024) 4 | 7.28 |
| Short % of float (28 Mar 2024) 4 | 10.68% |
| Short % of shares outstanding (28 Mar 2024) 4 | 7.06% |
| Shares short (prior month 29 Feb 2024) 4 | 3.28M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 1:14 |
| Last split date 3 | 29 Jan 2014 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | -46.37% |
| Operating margin (ttm) | -41.46% |
Management effectiveness
| Return on assets (ttm) | -8.33% |
| Return on equity (ttm) | -18.93% |
Income statement
| Revenue (ttm) | 143.27M |
| Revenue per share (ttm) | 3.28 |
| Quarterly revenue growth (yoy) | -26.00% |
| Gross profit (ttm) | N/A |
| EBITDA | -45.24M |
| Net income avi to common (ttm) | -66.43M |
| Diluted EPS (ttm) | -1.52 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 51.7M |
| Total cash per share (mrq) | 1.14 |
| Total debt (mrq) | 42.69M |
| Total debt/equity (mrq) | 12.64% |
| Current ratio (mrq) | 2.86 |
| Book value per share (mrq) | 7.48 |
Cash flow statement
| Operating cash flow (ttm) | -12.5M |
| Levered free cash flow (ttm) | -5.1M |
© 2024 Yahoo. All rights reserved.